Research Article
The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B
Table 3
Clinical characteristics of the CHB liver fibrosis and liver cirrhosis group cases (
).
| Clinical data | Liver fibrosis group | Liver cirrhosis group | |
| Male/female | 21/11 | 30/18 | 0.815 | Age (years old) | | | 0.0001 | Blood cell counts (109/L) | | | 0.025 | Hemoglobin (g/L) | | | 0.001 | Blood platelet (109/L) | | | 0.002 | ALT (U/L) | | | 0.285 | AST (U/L) | | | 0.023 | γ-GT (U/L) | | | 0.926 | ALP (U/L) | | | 0.985 | T-Bil (μmol/L) | | | 0.160 | D-Bil (μmol/L) | | | 0.177 | TP (g/L) | | | 0.244 | ALB (g/L) | | | 0.104 | TC (U/L) | | | 0.004 | TG (U/L) | | | 0.003 | AFP | | | 0.029 | INR | | | 0.001 | HBV-DNA (107 U/L) | | | 0.932 | HBeAg-positive rate (%) | 95% | 45% | 0.0001 |
|
|